INFORMATION FOR
News
Edward J. Miller, MD, PhD and Parul Gandhi, MD, welcome eleven outstanding trainees.
The new scientific statement from the AHA indicates multiple social, economic, and health variables contribute to disparities in the development, diagnosis, and treatment of PAD.
Routine, low-cost testing may reduce disparities and health care costs for people with peripheral artery disease (PAD), according to new American Heart Association scientific statement.
Black adults are more likely to undergo foot and leg amputations than white adults.
Standard testing that is inexpensive may help reduce disparities in care and lower the amputation risk for people with peripheral artery disease, according to a new science report.
A recent proposal has called for “whole-person, multidisciplinary interventions” for vascular specialty care services.
Connecticut Magazine's 2023 ‘Top Doctors’ list includes 16 faculty in the Section of Cardiovascular Medicine.
El Dr. Carlos Mena-Hurtado recibió un premio rally del centro de coordinación clínica por el liderazgo excepcional en el ensayo CREST-2.
Distress is associated with an increased risk of mortality and major amputation after peripheral vascular intervention (PVI).
Carlos Mena-Hurtado, MD, was appointed to serve on the Society for Vascular Surgery Patient Safety Organization (SVS PSO) Governing Council.
Carlos Mena-Hurtado, MD, received a Clinical Coordinating Center Rally award for outstanding leadership in the CREST-2 trial.
John Spertus, MD, MPH, an expert on the measurement of quality of care and health status in cardiovascular disease, will speak at the virtual VAMOS Research Meeting on Tuesday, April 18.
The Council on Peripheral Vascular Disease expert perspective provides interventions to improve PAD outcomes and patient satisfaction.
Almost one-half of the patients receiving a peripheral vascular intervention (PVI) between 2017 and 2018 were not on guideline-directed medical therapy (GDMT).
Half of Medicare patients who underwent a procedure for symptom relief for peripheral vascular disease did not receive the recommended medical therapy for long-term cardiovascular risk management.
Yale medical students develop clinical and research skills at Yale’s Vascular Medicine OutcomeS (VAMOS) lab.
Bypass surgery in artiries leading to the legs was associated with a lower risk of cardiac events among patients with peripheral arterial disease who are candidates for two types of revascularization therapy, new research suggests.
A systematic review and meta-analysis found a 24% increased risk of all-cause mortality and a trend toward an association between depression and major adverse limb events.
A meta-analysis of 119,123 patients with peripheral artery disease (PAD) demonstrates that depressive symptoms were associated with a 24 % increased risk of all-cause mortality.
The American Heart Association (AHA) released a scientific statement to advance the science and practice of PAD treatment.